Recruiting Pulmonary Fibrosis Studies in Washington D.c.
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
This study is open to people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). They can only take part if they have completed treatment in a previous study with a medic...
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Study RIN-PF-305 is designed to evaluate the safety and efficacy of inhaled treprostinil in subjects with progressive pulmonary fibrosis (PPF) over a 52-week period....
About Pulmonary Fibrosis Clinical Trials in Washington D.c.
Pulmonary fibrosis is a condition in which the lung tissue becomes damaged and scarred, making it difficult for the lungs to function properly. Idiopathic pulmonary fibrosis (IPF) is the most common form with unknown cause. Antifibrotic medications can slow progression, and lung transplant may be considered.
There are currently 2 pulmonary fibrosis clinical trials recruiting participants in Washington D.c., DC. These studies are seeking a combined 2,398 participants. Research is being sponsored by Boehringer Ingelheim, United Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Fibrosis Clinical Trials in Washington D.c. — FAQ
Are there pulmonary fibrosis clinical trials in Washington D.c.?
Yes, there are 2 pulmonary fibrosis clinical trials currently recruiting in Washington D.c., DC. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Washington D.c.?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Washington D.c. research site will contact you about next steps.
Are clinical trials in Washington D.c. free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Washington D.c. studies also compensate for your time and travel.
What pulmonary fibrosis treatments are being tested?
The 2 active trials in Washington D.c. are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary fibrosis.
Data updated March 2, 2026 from ClinicalTrials.gov